Últimas noticias sobre Redhill Biopharma (NASDAQ:RDHL) Bolsa

Redhill Biopharma

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

Redhill Biopharma Ltd. - American Depositary Shares

Redhill Biopharma Ltd

Canadian retailers continue to take a stand against U.S. products, starting with non-essential items such as alcohol. This move, driven by recent tariff disputes, is affecting various segments of the agricultural supply chain.
What Happened:&nbsp;Alisa Gorokhova, a resident from Quebec, observed a rapid shift in consumer behavior following tariff announcements, according <a href="https://www.businessinsider.com/canadian-grocers-sideline-us-products-boycott-hit-us-agriculture-businesses-2025-3">to</a> a report by Business Insider.
&#8220;There&#8217;s suddenly &#8216;made in Canada&#8217;&nbsp;labels on things and American&nbsp;booze is gone from the&nbsp;shelves,&#8221; she mentioned, indicating a growing preference for Canadian-made products.
The boycott is a response to repeated tariff impositions by former President&nbsp;Donald Trump, including&nbsp;a 25% tax on Canadian&nbsp;steel and aluminum. Trump&#8217;s controversial remarks about Canada have further strained relations.
American businesses are feeling the&nbsp;impact.&nbsp;Ethan Frisch, CEO of&nbsp;Burlap &amp; Barrel, reported losing Canadian customers.
&#8220;We're&nbsp;not really sure how to&nbsp;handle this,&#8221; Frisch stated, as the boycott contradicts his company&#8217;s mission of supporting small farmers, according to the report.
See Also: <a href="https://www.benzinga.com/markets/equities/25/03/44271204/tsmc-proposes-joint-venture-with-nvidia-amd-and-broadcom-to-operate-intels-factories-report">TSMC Proposes Joint Venture With Nvidia, AMD And Broadcom To Operate Intel&#8217;s Factories: Report</a>
Large Canadian grocery chains like&nbsp;Sobeys Inc.&nbsp;and&nbsp;Metro Inc.&nbsp;are emphasizing local products. Sobeys, for instance, is working to reduce its reliance on U.S. goods, which previously accounted for 12% of sales.
Why It Matters: The trade tensions between the United States and Canada have escalated significantly.
Canada <a href="https://www.benzinga.com/news/25/03/44281882/canada-retaliates-with-20b-in-tariffs-on-us-goods-amid-trade-war">imposed 25% tariffs</a> on over $20 billion worth of U.S. goods, including steel and aluminum, as a countermeasure to the Trump administration&#8217;s new duties.
This move was confirmed by Canadian Finance Minister&nbsp;Dominic LeBlanc, who stated that the tariffs would take effect immediately. The situation intensified when Canada announced additional tariffs on $30 billion of U.S. goods earlier in March.
Further complicating matters,&nbsp;<a href="https://www.benzinga.com/25/03/44344906/canadas-retaliatory-tariffs-against-us-draw-commerce-secretary-howard-lutnicks-ire-who-thinks-they-are-tone-deaf-">Canada&#8217;s retaliatory tariffs</a>&nbsp;have drawn criticism from U.S. Commerce Secretary&nbsp;Howard Lutnick, who described them as &#8220;tone deaf.&#8221;
Meanwhile,&nbsp;<a href="https://www.benzinga.com/news/25/03/44326649/does-canada-really-have-a-250-tariff-in-place-on-us-dairy-products-imported-into-canada-here-are-the-facts">claims of high tariffs</a>&nbsp;on U.S. dairy products have added to the tension, with President Trump accusing Canada of unfair trade practices.
Additionally,&nbsp;Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)&nbsp;has been affected, as its products were <a href="https://www.benzinga.com/markets/25/03/44321211/tesla-charging-stations-cut-from-rebate-program-by-canadian-province-most-people-would-support-their-removal-from-subsidy-list-says-minister">excluded from rebates</a> in British Columbia amid these trade tensions.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44299887/tsla-stock-may-see-a-significant-upswing-says-jim-cramer-should-be-ready-to-rally-maybe-furiously">TSLA Stock May See A Significant Upswing, Says Jim Cramer: &#8216;Should Be Ready To Rally, Maybe Furiously&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

News

Politics

Global

Economics

TSLA

Canadian Grocers Boycott US Products As Tariffs, Trump's Annexation Remarks Worsen Tensions: 'American Booze Is Gone From The Shelves'

A U.S. appeals court has permitted the Trump administration to temporarily enforce&nbsp;a ban on diversity, equity, and inclusion (DEI) programs within federal agencies and businesses holding government contracts.
What Happened: A U.S. appeals court has allowed the Trump administration to temporarily enforce&nbsp;a ban on diversity, equity, and inclusion (DEI)&nbsp;programs at federal agencies and&nbsp;businesses with government contracts.
According to&nbsp;a Reuters report, the Richmond-based&nbsp;4th U.S. Circuit Court of&nbsp;Appeals ruled on Friday that President&nbsp;Donald Trump&#8216;s directives, including an order for&nbsp;the Department of Justice to&nbsp;investigate DEI policies, are likely constitutional.
This decision overturns a previous ruling by a Maryland federal judge.
Two judges on the panel expressed disagreement with the substance of Trump&#8217;s orders, cautioning that implementing them might risk constitutional violations.
Circuit Judge Albert Diaz stated that DEI advocates deserve praise, while Circuit Judge Allison Rushing emphasized that personal opinions on DEI should not influence the case&#8217;s outcome.
The decision affected a lawsuit filed by the city of Baltimore and three groups, which remained in effect pending the Trump administration&#8217;s appeal.
The White House and Justice Department have not commented, while Democracy Forward, representing the plaintiffs, is reviewing the decision.
Trump&#8217;s orders aim to eliminate DEI initiatives, which he argues are discriminatory, from both government and private sectors.
Why It Matters: The ruling comes amid a broader political and policy shift affecting DEI initiatives.
Recently, the&nbsp;<a href="https://www.benzinga.com/25/03/44200499/national-institutes-of-health-terminates-some-research-grants-amid-political-and-policy-shift">National Institutes of Health (NIH)</a>&nbsp;began cutting funding for research grants that do not align with agency priorities, specifically targeting studies on transgender populations and DEI.
Additionally, in January, President Trump controversially linked DEI policies to a tragic&nbsp;<a href="https://www.benzinga.com/25/01/43402439/trump-musk-blame-dei-for-plane-crash-authorities-look-at-staffing-congestion-for-answers-search-continues-after-41-bodies-found">plane crash</a>&nbsp;involving an American Airlines plane and an Army helicopter, which resulted in 67 fatalities.
This incident further fueled the administration&#8217;s stance against DEI, as Trump suggested that staffing and regulatory changes influenced by DEI could have contributed to the crash.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44344906/canadas-retaliatory-tariffs-against-us-draw-commerce-secretary-howard-lutnicks-ire-who-thinks-they-are-tone-deaf-">Canada's Retaliatory Tariffs Against US Draw Commerce Secretary Howard Lutnick's Ire Who Thinks They Are ‘Tone Deaf'</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Trump's Ban On DEI Programs Allowed For Now By Appeals Court

In a significant escalation of trade tensions,&nbsp;Canada&nbsp;has introduced retaliatory tariffs against the U.S., prompting criticism from&nbsp;Commerce Secretary Howard Lutnick. The move follows the Trump administration&#8217;s recent trade measures targeting Canadian exports.
What Happened: Lutnick expressed dissatisfaction with Canada&#8217;s &#8220;tone deaf&#8221; approach in an interview ahead of a meeting with Canadian officials on Thursday.
Canada&#8217;s tariffs target $15.6 billion&nbsp;worth of U.S. steel and&nbsp;aluminum, mirroring the U.S. tariffs on metals. Additionally, Canada imposed tariffs on $14.2 billion worth of other goods, including tools, computers, and sports equipment.
Lutnick criticized these measures, stating, &#8220;We&nbsp;put a tariff on steel&nbsp;and aluminum to make sure&nbsp;the dumping countries of the&nbsp;world stop&#8230;&nbsp;And what does Canada do?&nbsp;They put a tariff on&nbsp;sports equipment.&#8221;
"I mean really? This is just tone deaf," he said, according <a href="https://fortune.com/2025/03/14/commerce-secretary-howard-lutnick-canada-trump-tariff-response-mexico-uk/">to</a> Fortune.
Lutnick defended the U.S. tariffs as necessary for national security, emphasizing the importance of domestically produced materials for defense purposes.
He accused Canada of relying heavily on the U.S. for protection while contributing less to NATO, citing Canada&#8217;s 2024 contribution of $30.5 billion compared to the U.S.&#8217;s $967 billion.
Despite the tensions, Ontario Premier Doug Ford described the meeting with Lutnick as &#8220;productive&#8221; and expressed optimism about future discussions. Both countries&#8217; tariffs remain in place, but Ford praised Lutnick&#8217;s business acumen and negotiation skills.
Why It Matters: The trade tensions between the U.S. and Canada have been escalating, with Canada announcing plans to impose 25% tariffs on over $20 billion worth of U.S. goods.
This move <a href="https://www.benzinga.com/news/25/03/44281882/canada-retaliates-with-20b-in-tariffs-on-us-goods-amid-trade-war">targets</a> a wide range of products, including steel, aluminum, and sports equipment. The Canadian response is a direct counter to the U.S. tariffs on metals, which were justified by the Trump administration on national security grounds.
Elon Musk-led Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) has seen its products <a href="https://www.benzinga.com/markets/25/03/44321211/tesla-charging-stations-cut-from-rebate-program-by-canadian-province-most-people-would-support-their-removal-from-subsidy-list-says-minister">excluded</a> from rebates in British Columbia, a move linked to the ongoing trade tensions.
This exclusion affects Tesla&#8217;s electric vehicle charging stations and home batteries, highlighting the broader impact of the trade dispute on various industries.
Furthermore, the dairy sector has been a point of contention, with high tariffs on U.S. dairy products being a <a href="https://www.benzinga.com/news/25/03/44326649/does-canada-really-have-a-250-tariff-in-place-on-us-dairy-products-imported-into-canada-here-are-the-facts">longstanding issue</a>. These tariffs can reach up to 298.5% when U.S. exports exceed quotas set under the United States-Mexico-Canada Agreement.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44299887/tsla-stock-may-see-a-significant-upswing-says-jim-cramer-should-be-ready-to-rally-maybe-furiously">TSLA Stock May See A Significant Upswing, Says Jim Cramer: &#8216;Should Be Ready To Rally, Maybe Furiously&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Canada's Retaliatory Tariffs Against US Draw Commerce Secretary Howard Lutnick's Ire Who Thinks They Are 'Tone Deaf:' 'The British Didn't Respond, The Mexicans Didn't Respond…'

SAIH

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

FAMI

BHAT

WKHS

SPGC

ADTX

WLDS

Freeport-McMoRan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) has outperformed the market over the past 5 years by 25.72% on an annualized basis producing an average annual return of 43.07%. Currently, Freeport-McMoRan has a market capitalization of $55.69 billion. 
Buying $1000 In FCX: If an investor had bought $1000 of FCX stock 5 years ago, it would be worth $6,225.96 today based on a price of $38.75 for FCX at the time of writing.
<h3>Freeport-McMoRan's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741995909_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning Freeport-McMoRan Stock In The Last 5 Years

PENN Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>) has outperformed the market over the past 5 years by 1.09% on an annualized basis producing an average annual return of 18.45%. Currently, PENN Entertainment has a market capitalization of $2.62 billion. 
Buying $100 In PENN: If an investor had bought $100 of PENN stock 5 years ago, it would be worth $200.12 today based on a price of $17.10 for PENN at the time of writing.
<h3>PENN Entertainment's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741995008_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PENN

$100 Invested In PENN Entertainment 5 Years Ago Would Be Worth This Much Today

Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) has outperformed the market over the past 10 years by 7.0% on an annualized basis producing an average annual return of 17.38%. Currently, Visa has a market capitalization of $639.27 billion. 
Buying $1000 In V: If an investor had bought $1000 of V stock 10 years ago, it would be worth $4,958.34 today based on a price of $331.40 for V at the time of writing.
<h3>Visa's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741994115_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

Costco Wholesale Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) has built its reputation on low prices, loyal customers, and a business model that rarely wavers. In a recent interview with <a href="https://chiefexecutive.net/the-costco-way-a-conversation-with-tony-james/">Chief Executive</a> magazine, Chair Hamilton "Tony" James reflected on the late Charlie Munger's deep influence on the company.&nbsp;
Munger, best known as <a href="https://www.benzinga.com/startups/25/02/43451833/warren-buffetts-1m-bet-why-simple-index-funds-crushed-hedge-funds-by-7-1-to-2-2-over-a-decade">Warren Buffett'</a>s longtime partner at Berkshire Hathaway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>, BRK.B)), spent over 25 years on Costco's board, pushing a simple but effective message: "Stick to our knitting, our values, and our principles." That philosophy has shaped how the retailer operates to this day.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>
<h2 class="wp-block-heading">Munger's Influence on Costco's Growth</h2>
Munger wasn't just a board member—he was a true believer. He once called himself a "total addict" of the store, adding, "I love everything about Costco. I'm never going to sell a share." And he meant it. <a href="https://www.fool.com/investing/2023/11/01/billionaire-investor-charlie-munger-costco-stock/">The Motley Fool</a> reported his stake in the company was worth over $100 million in 2023.
One of Costco's most famous traditions—the $1.50 hot dog and soda combo—stands as proof of its commitment to keeping prices low. It hasn't changed since 1985, even as costs rise everywhere else.
When former CEO Craig Jelinek suggested raising the price, co-founder Jim Sinegal reportedly shut him down: "If you raise the [price of the] effing hot dog, I will kill you. Figure it out." To save on costs, Costco switched from Coca-Cola to Pepsi in 2013.
Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>
Now, the company plans to bring back Coca-Cola products in its food courts. The company's ability to attract all kinds of shoppers, including wealthy ones, is another reason for its success.&nbsp;
James pointed out that "affluent people love a good deal." That's why Costco stocks luxury items like Rolex watches, Dom Perignon champagne, and 10-carat diamonds. A Porsche dealership in Seattle even displayed cars at a Costco warehouse once, and they sold out in a week.
But not everyone sees Costco's model as foolproof. Some suppliers have complained about its aggressive cost-cutting. A former vendor, in a post on<a href="https://www.reddit.com/r/Costco/comments/istmpc/costco_ruined_my-business_warning-and-rant/"> Reddit</a>, claimed that Costco's pricing demands forced them to slash wages and adopt unsustainable practices.&nbsp;
See Also: Have $200K saved?<a href="https://www.benzinga.com/money/have-200k-saved-heres-how-to-turn-it-into-lasting-wealth"> Here's how to turn it into lasting wealth</a>
Others question how long the company can rely on low-margin goods and membership fees.<a href="https://www.investopedia.com/articles/markets/011216/4-problems-costcos-business-model-cost.asp"> Investopedia</a> notes that this approach could put long-term pressure on earnings.
Recent financial results have also raised concerns. Rising merchandise <a href="https://www.benzinga.com/personal-finance/25/03/44147801/egg-prices-hit-record-4-95-per-dozen-agriculture-secretary-blames-overregulation-for-skyrocketing-cost">costs</a> led Costco to miss profit estimates, <a href="https://www.reuters.com/business/retail-consumer/costco-beats-quarterly-sales-estimates-bulk-buying-surge-2025-03-06/">Reuters</a> reported. Still, the retailer's bulk-selling strategy and loyal customer base keep it strong.
Read Next:
<ul>
<li>Dogecoin millionaires are increasing –<a href="https://www.benzinga.com/money/dogecoin-millionaires"> investors with $1M+ in DOGE revealed!</a></li>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
</ul>

Personal Finance

COST

Why Charlie Munger Never Sold A Single Costco Share—The Billionaire Investor Called Himself A 'Total Addict' Of The Store

Schlumberger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) has outperformed the market over the past 5 years by 6.68% on an annualized basis producing an average annual return of 24.03%. Currently, Schlumberger has a market capitalization of $55.76 billion. 
Buying $1000 In SLB: If an investor had bought $1000 of SLB stock 5 years ago, it would be worth $2,852.19 today based on a price of $41.00 for SLB at the time of writing.
<h3>Schlumberger's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741993209_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Schlumberger 5 Years Ago Would Be Worth Today

Insulet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PODD#NASDAQ">PODD</a>) has outperformed the market over the past 10 years by 11.82% on an annualized basis producing an average annual return of 22.21%. Currently, Insulet has a market capitalization of $17.94 billion. 
Buying $100 In PODD: If an investor had bought $100 of PODD stock 10 years ago, it would be worth $743.21 today based on a price of $255.44 for PODD at the time of writing.
<h3>Insulet's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741991416_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PODD

$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

Tariffs are <a href="https://www.benzinga.com/personal-finance/25/03/44172672/dave-ramsey-says-no-question-tariffs-will-100-raise-prices-walmart-doesnt-pay-taxes-you-pay-taxes-when-you-buy-potato-chips-at-walmart">back in the headlines</a>, and "The Ramsey Show" co-host Ken Coleman isn't having it. In a recent <a href="https://www.youtube.com/watch?v=oODl8YOhtx8">episode</a>, a caller's financial dilemma turned into a fiery discussion on trade wars, economic policy, and why tariffs hit everyday workers harder than politicians like to admit.
The caller, Isaiah from Grand Rapids, Michigan, had been steadily working his way out of debt—following Dave Ramsey's famous Baby Steps—when news of Mexico's retaliation tariffs threw a wrench into his financial plans. His employer, a medical supply company, had already moved production from China to Mexico, and now, with new tariffs in play, they were staring down "significant, significant losses." While leadership hadn't announced layoffs yet, the writing was on the wall.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a></li>
<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
</ul>
Isaiah and his wife were on their seventh or eighth week of Financial Peace University and had been making steady progress. They had $51,000 left in debt—a mix of student loans, medical debt, and an old refinance mistake—and were earning $120,000 a year. Their goal? Knock out the remaining balance in two to three years. But with potential job insecurity, Isaiah wasn't sure if they should keep throwing extra cash at debt or pause and build up savings as a safety net.
That's when Coleman jumped in, first digging into the details of the company's situation. Isaiah confirmed that roughly 17% to 18% of their business was affected by imports from Mexico. The problem? The company had fixed contracts in the medical industry—meaning they couldn't simply raise prices to offset the tariff costs. Instead, their profit margins were shrinking, which could lead to budget cuts, layoffs, or worse.
Trending: Dogecoin millionaires are increasing –<a href="https://www.benzinga.com/money/dogecoin-millionaires"> investors with $1M+ in DOGE revealed!</a>
Coleman, a longtime free-trade advocate, didn't hold back:
"That's why guys like me, free traders, I don't like tariffs. Never going to like tariffs. So don't @ me or send me hate email, I'm not going to read it. And I'm right. So we'll just leave it at that. Tariffs become taxes. It's just that simple."
His frustration was clear—this wasn't just political theory; it was real-life economics hitting a caller's paycheck. And Coleman wasn't done. He pointed out that tariffs create a domino effect: businesses struggle, prices go up, wages stagnate, and in some cases, people lose their jobs.
But what about Isaiah's original question? Should he pause his debt payoff plan?
Co-host George Kamel stepped in with a measured response:
<ul>
<li>No, don't pause just yet. There wasn't enough concrete evidence that layoffs were imminent.</li>
<li>Yes, stay alert. Keep an eye on company updates, and if job cuts start looking inevitable, then it might be time to hit pause and stack up cash.</li>
<li>Consider a backup plan. Isaiah's skills were in demand, so it might be smart to start looking for other job opportunities in case things went south.</li>
</ul>
That's when the conversation took a broader turn into headlines vs. guidelines.
See Also: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Coleman warned against reacting emotionally to news cycles, pointing out that media headlines thrive on fear—whether it's a 900-point stock market drop, trade war speculation, or recession predictions. Instead, he urged listeners to focus on guidelines—financial principles that keep people secure no matter what's happening in the economy. He added, "The stuff that we teach makes you recession-proof."&nbsp;
The segment wrapped with a blunt reality check: if the government is going to impose tariffs, they need to also deregulate and cut business taxes so companies can <a href="https://www.benzinga.com/personal-finance/25/03/44227970/from-cars-to-avocados-whats-spared-in-trumps-tariff-pause">afford to produce goods domestically</a>. Otherwise, the result is exactly what Isaiah was experiencing—businesses caught in the crossfire, scrambling to cover costs, and employees left wondering if they'll have a job tomorrow.
Read Next:
<ul>
<li>It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
<li><a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a></li>
</ul>

'Tariffs Become Taxes' — Ramsey Host Warns of Trade War Fallout as Medical Worker Worries Mexico's Retaliation Tariffs Could Put His Job at Risk

FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) has outperformed the market over the past 20 years by 5.78% on an annualized basis producing an average annual return of 13.96%. Currently, FactSet Research Systems has a market capitalization of $16.61 billion. 
Buying $1000 In FDS: If an investor had bought $1000 of FDS stock 20 years ago, it would be worth $13,318.60 today based on a price of $436.85 for FDS at the time of writing.
<h3>FactSet Research Systems's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741989638_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In FactSet Research Systems 20 Years Ago Would Be Worth Today

Harold Hamm, oil magnate and founder of Continental Resources, issued a stark warning: if oil prices remain at current levels, drilling in key U.S. shale fields could <a href="https://www.benzinga.com/25/03/44168987/oil-prices-hit-multi-year-lows">come to a standstill. </a>
The Details: Speaking at CERAWeek in Houston, Hamm emphasized that with oil prices hovering near $65 per barrel, many fields are already struggling to remain viable.&nbsp;
"When you get below the cost of supply, you can't ‘drill, baby, drill,'" he told Bloomberg, per OilPrice.com.
Read Next: <a href="https://www.benzinga.com/government/regulations/25/03/44310724/doge-cuts-to-ftc-sow-confusion-in-case-against-amazon">DOGE Cuts To FTC Sow Confusion In Case Against Amazon</a>&nbsp;
While industry leaders have applauded the rollback of Biden-era climate regulations, Trump's trade policies—particularly his tariff disputes with Canada—are creating uncertainty and further pressuring crude oil prices. Trump has described the lower prices as "phenomenal news," but many in the oil sector are expressing concern.&nbsp;
"There are a lot of fields that are getting to the point that's real tough to keep that cost of supply down," Hamm told Bloomberg Television.&nbsp;
"When you get down to that $50 oil that you talked about, then you're below the point where you're going to ‘drill, baby, drill.'"
ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) CEO Ryan Lance also highlighted inflationary pressures and investor anxiety over Trump's unpredictable trade policies affecting the industry.&nbsp;
Scott Sheffield, former CEO of Pioneer Natural Resources, told Bloomberg Television that the price publicly traded oil drillers need to cover costs and turn a profit is between $50 and $55 a barrel. 
The oil industry could be at a turning point as low oil prices benefit consumers but pose significant challenges for producers. 
The United States Oil Fund LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>) ETF, tracking the daily price movements of light, sweet crude oil, is down more than 4% in 2025. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/03/44253259/uncertainty-rocks-the-trump-trade-how-maga-seven-stocks-look-now">Uncertainty Rocks The Trump Trade: How &#8216;MAGA Seven&#8217; Stocks Look Now</a></li>
</ul>
Image: Shutterstock&nbsp;

Specialty ETFs

Commodities

Management

Markets

ETFs

Oil Titan Harold Hamm Warns Drilling Could Stop If Oil Prices Remain Low: 'You Can't Drill, Baby, Drill'

Castellum, Inc. (the "Company" or "Castellum") (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, today announced that it intends to offer and sell shares of its common stock and warrants exercisable into shares of the Company's common stock, in a public offering. All of the shares of common stock are being offered by Castellum. Castellum initially intends to use the net proceeds of the offering for working capital and general corporate purposes. Consummation of the offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Maxim Group LLC is acting as the sole placement agent for the offering on a reasonable best-efforts basis.

Offerings

Castellum Announces Proposed Public Offering Of Common Stock And Warrants; No Size Or Amount Disclosed

Press Releases

Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors

RedHill Biopharma Awarded Judgment of Approximately $8 Million Plus Costs by New York Supreme Court

Supreme Court Of New York Awards RedHill Biopharma Approx. $8 Million Plus Costs In Breach Of Contract Lawsuit

Radioprotective Activity of RedHill's Opaganib for GI-ARS Confirmed in New RNCP/NIAID Study - Discussions Ongoing with U.S. Government on Advanced Development

RedHill's Talicia® Adds 8 Million Lives With Coverage by Humana®'s Part D Plan. Also, New Data Supporting Simplified Three-Times Daily Talicia Dosing Published

RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer

New Prostate Cancer Hope? Bayer-Funded Phase 2 Study To Test Combination Of RedHill's Opaganib And Bayer's Darolutamide, To Overcome Androgen Resistance

RedHill Licenses RHB-102 for Commercialization Worldwide Excluding North America to Hyloris for up to $60 Million in Potential Milestone Payments Plus Royalties

RedHill Presents Business Update at the Sachs' European Life Sciences CEO Forum

RedHill Biopharma Advances its Groundbreaking Late-Stage Crohn's Disease Program Building on Statistically Significant Positive RHB-104 Phase 3 Results

ATNM

AVTX

RDHL

TENX

Adial Pharmaceuticals, Inc - Common Stock

Adial Pharmaceuticals

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics

Akanda

Artelo Biosciences

Avenue Therapeutics

Aytu BioPharma

CNS Pharma

China Pharma Holding

Enveric Biosciences

Evoke Pharma

Eyenovia

Impact BioMedical

Jaguar Health

NovaBay Pharmaceuticals, Inc. Common Stock

NovaBay Pharmaceuticals

Processa Pharmaceuticals, Inc. - Common Stock

Processa Pharma

Purple Biotech Ltd. - American Depositary Shares

Purple Biotech

Petros Pharmaceuticals, Inc. - Common Stock

Petros Pharma

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

SenesTech

Sonoma Pharmaceuticals, Inc. - Common Stock

Sonoma Pharmaceuticals

60 Degrees Pharmaceuticals, Inc. - Common Stock

60 Degrees

Titan Pharmaceuticals, Inc. - Common Stock

Titan Pharma

Universe Pharmaceuticals Inc - Ordinary Shares

Universe Pharmaceuticals

Virpax Pharmaceuticals, Inc. - Common Stock

Virpax Pharmaceuticals

cbdMD

Screenshot 2025-02-25 at 7.29.32 PM

Biotech

General

RedHill Licenses RHB-102 Worldwide Excluding North America To Hyloris For Up To $60M In Potential Milestone Payments Plus Royalties

Screenshot 2025-02-04 at 6.43.58 PM

BAYRY

New Prostate Cancer Hope? Bayer-Funded Phase 2 Study To Test Combination Of RedHill&#39;s Opaganib And Bayer&#39;s Darolutamide, To Overcome Androgen Resistance

Comments

Redhill Biopharma

Noticias

Últimas noticias sobre Redhill Biopharma (NASDAQ:RDHL) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL